WYVETTE LEONI: Open Payments
NPI 1316655061 · MT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,679 in 85 payments from 19 companies in 2025. Trend: 2023 $3,590 · 2024 $2,849 · 2025 $2,679
Food & beverage: $2,679
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $578 |
| Janssen Pharmaceuticals, Inc | 10 | $382 |
| E.R. Squibb & Sons, L.L.C. | 8 | $360 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $258 |
| Alkermes, Inc. | 2 | $144 |
| Neurocrine BioSciences, Inc. | 2 | $121 |
| Axsome Therapeutics, Inc. | 1 | $115 |
| Vanda Pharmaceuticals Inc. | 4 | $91 |
| Corium, LLC | 3 | $89 |
| Collegium Pharmaceutical, Inc. | 5 | $87 |
Products named: VRAYLAR, SPRAVATO, COBENFY, CAPLYTA, QULIPTA, LYBALVI, REXULTI, INGREZZA.
Industry payments across SC — which companies pay providers there.
